Back to 
FEDERATED HERMES, INC.
FEDERATED HERMES, INC.
JANX3 quarters
Position history for FEDERATED HERMES, INC.'s holdings in JANUX THERAPEUTICS INC
Yes. Federated Hermes holds 2,352,927 shares of JANX (Janux Therapeutics), worth $36.1M, as of its Q2 2026 13F filing. It increased the position from 54,200 shares in Q1 2026. Federated Hermes has held JANX since Q4 2025, across 3 quarterly 13F filings. JANX is 0.1% of Federated Hermes' reported 13F portfolio.
Current Value
$36.1M
Current Shares
2.4M
Total Value Change
+$36M
Total Shares Change
+2.3M
Quarter-by-Quarter History
Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC